Inventor · disambiguated record
Li Long
Also filed as: LONG LI · Long Li Juan
15 granted patents·14 pending applications·203 citations·filing 2004–2021
92Inventor score
Files withCHIRON CORP5EUREKA THERAPEUTICS INC5NOVARTIS VACCINES & DIAGNOSTICS INC5FIVE PRIME THERAPEUTICS INC4LONG LI3
Top patents by PatentIndex Score
29 records- 0194US8277810B2Antagonist anti-CD40 antibodiesLONG LI·Filed 2007·Granted Oct 2, 2012·54 cites·50 claims
- 0293US8637032B2Antagonist anti-CD40 monoclonal antibodies and methods for their useLONG LI·Filed 2012·Granted Jan 28, 2014·39 cites·69 claims
- 0392US10011658B2Constructs targeting AFP peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Jul 3, 2018·14 cites·24 claims
- 0492US8080246B2Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion moleculesLIN HAISHAN·Filed 2009·Granted Dec 20, 2011·49 cites·24 claims
- 0589US9926371B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2016·Granted Mar 27, 2018·7 cites·17 claims
- 0689US9079956B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Granted Jul 14, 2015·11 cites·30 claims
- 0789US8183207B2Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion moleculesLIN HAISHAN·Filed 2009·Granted May 22, 2012·24 cites·12 claims
- 0882US10301388B2Antibody agents specific for human CD19 and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·2 cites·19 claims
- 0981US8951972B2FGFR1 extracellular domain combination therapies for lung cancerLONG LI·Filed 2011·Granted Feb 10, 2015·2 cites·6 claims
- 1072US9522186B2M-CSF specific monoclonal antibody and uses therofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2015·Granted Dec 20, 2016·1 cites·22 claims
- 1169US11034759B2Humanized M-CSF specific monoclonal antibodies, kits, and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2018·Granted Jun 15, 2021·0 cites·27 claims
- 1269US2021277117A1Constructs targeting afp peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1368US2015203566A1Fgfr1 extracellular domain combination therapiesFIVE PRIME THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1466US11981742B2Antibody agents specific for human CD19 and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted May 14, 2024·0 cites·16 claims
- 1561US2018002399A1Fgfr1 extracellular domain combination therapiesFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1661US2018171009A1M-CSF Specific Monoclonal Antibody and Uses ThereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2018·Application pending·0 cites
- 1758US2014205602A1Antagonist anti-cd40 monoclonal antibodies and methods for their useNOVARTIS VACCINES & DIAGNOSTIC·Filed 2013·Application pending·0 cites
- 1856US2009324604A1M-csf specific monoclonal antibody and uses thereofCHIRON CORP·Filed 2005·Application pending·0 cites
- 1955US11709991B2Detecting truncation and overlap defects on webpageIBM·Filed 2021·Granted Jul 25, 2023·0 cites·20 claims
- 2053US10537611B2Methods of treating lung cancerFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·0 cites·20 claims
- 2152US2017081416A1Antagonist anti-cd40 monoclonal antibodies and methods for their useNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2016·Application pending·0 cites
- 2250US10016484B2Methods of treating lung cancerFIVE PRIME THERAPEUTICS INC·Filed 2012·Granted Jul 10, 2018·0 cites·20 claims
- 2350US2022101148A1Machine learning enhanced tree for automated solution determinationIBM·Filed 2020·Application pending·0 cites
- 2448US2018208658A1Constructs targeting afp peptide/mhc complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2546US2008057070A1Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their UseCHIRON CORP·Filed 2004·Application pending·0 cites
- 2646US2007110754A1Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemiaCHIRON CORP·Filed 2004·Application pending·0 cites
- 2745US2007098718A1Methods of therapy for b cell-related cancersCHIRON·Filed 2004·Application pending·0 cites
- 2845US2007098717A1Methods of therapy for solid tumors expressing the cd40 cell-surface antigenCHIRON CORP·Filed 2004·Application pending·0 cites
- 2945US2007218060A1Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple MyelomaCHIRON CORP·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Li Long files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →